Taysha GTx
  • About
    • Who We Are
    • UTSW Partnership
    • Our Team
      • Leadership
      • Board of Directors
      • Advisors
  • Approach
    • Proven Gene Therapy Strategy
      • AAV9
      • Intrathecal Dosing
      • Manufacturing
    • Next Generation Platforms
      • AAV Redosing Platform
      • Regulated Transgene Expression Platform
      • Novel Capsid Platform
  • Pipeline
    • Overview
    • TSHA-101
    • TSHA-102
    • TSHA-118
  • Patients & Caregivers
    • Patient Guiding Principles
    • Contact
  • Investors
    • News & Events
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Careers
    • Heart of Taysha
    • Open Positions
  • Contact
  • Menu Menu

BRINGING NEW CURES TO LIFE.

At Taysha Gene Therapies, we believe in a world where monogenic CNS disease can be eradicated.

And we believe that world is within our reach.

What Does Taysha Mean?

Taysha is a word in the Caddo Native American language meaning “ally” or “friend,” and when translated, also means “Texas.” We are committed to being an ally to the rare disease community.

Our vision is bold, and we’ve assembled the right pieces to help make it a reality.

A new approach, based on a proven method.

Our strategy is to advance a pipeline of gene therapies that serve a population of patients who suffer from diseases with high unmet medical needs. Our proven approach bridges the gap between innovation and a potential cure.

Learn About Our Approach

Experts in gene therapy – and putting patients first.

We’ve reunited the top talent in gene therapy and together, we believe we can discover, develop, and commercialize novel gene therapies for both rare and large patient populations.

Meet Our Team

A pipeline built on 18 gene therapies.

We are advancing an extensive AAV gene therapy pipeline, with each medicine targeting the underlying biology of the specific indication. Our lead candidates include potential treatments for GM2 gangliosidosis, Rett syndrome and CLN1.

View Our Pipeline and Programs

Recent News

The latest from Taysha Gene Therapies.

  • Taysha Gene Therapies Continues to Add Significant Gene Therapy Expertise to Leadership Team with the Appointment of Chief Legal Officer and Chief People Officer

  • Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency

  • Taysha Gene Therapies and UT Southwestern Medical Center Launch Innovation Fund to Accelerate Advancement of AAV Gene Therapies for Monogenic Diseases of the Central Nervous System

Read More
  • About
    • Who We Are
    • UTSW Partnership
    • Our Team
      • Leadership
      • Board of Directors
      • Advisors
  • Approach
    • Proven Gene Therapy Strategy
      • AAV9
      • Intrathecal Dosing
      • Manufacturing
    • Next Generation Platforms
      • AAV Redosing Platform
      • Regulated Transgene Expression Platform
      • Novel Capsid Platform
  • Pipeline
    • Overview
    • TSHA-101
    • TSHA-102
    • TSHA-118
  • Patients & Caregivers
    • Patient Guiding Principles
    • Contact
  • Investors
    • News & Events
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Shareholder Resources
  • Careers
    • Heart of Taysha
    • Open Positions
  • Contact
Copyright 2021- Taysha GTx
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OKLearn more

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsHide notification only